Aurobindo Pharma gets warning letter from US FDA for Andhra Pradesh unit
The company received a warning letter from the United States Food and Drug Administration (US FDA) related to their unit XI,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Aurobindo Pharma » Page 2
Browsing Tag
Aurobindo Pharma
Aurobindo to expand into EU, US over next three to four years
The company looks to launch various new products in the US market
Aurobindo Pharma gets US FDA nod for anaesthetic injection
The product is expected to be launched in the second quarter of 2016-17 fiscal, it added
Aurobindo Pharma gets US FDA nod for valganciclovir tabs
Valganciclovir tablets is an anti-viral used in the treatment of Cytomegalovirus (CMV) retinitis
Aurobindo Pharma received final…
Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules
The product is expected to be launched in Q1 FY16-17
Aurobindo Pharma receives US FDA approval for Acetylcysteine injection
The product is likely to be launched in Q1 FY16-17
Aurobindo Pharma gets US FDA approval for norethindrone acetate tabs
The tablets are used in the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary…
Aurobindo Pharma gets shareholders’ nod to raise up to $600 million
The funds will facilitate and meet the additional capital expenditure requirements for the ongoing and future projects of the…
Aurobindo Pharma receives US FDA approval for allergic conjunctivitis solution
The approved product has an estimated market size of $235 million
Aurobindo Pharma receives USFDA approval for methylprednisolone sodium succinate injection
The approved product has an estimated market size of $102 million for the twelve months ending October 2015 according to IMS…